|
Volumn 1, Issue 2, 2006, Pages 143-153
|
Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ATORVASTATIN;
AZETIDINE DERIVATIVE;
CLOFIBRIC ACID;
EZETIMIBE;
FLUINDOSTATIN;
FLUOROBENZENE;
HEPTANOIC ACID DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
INDOLE DERIVATIVE;
MONOUNSATURATED FATTY ACID;
PRAVASTATIN;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
ROSUVASTATIN;
SIMVASTATIN;
SULFONAMIDE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
HUMAN;
REVIEW;
AMLODIPINE;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
CLOFIBRIC ACID;
FATTY ACIDS, MONOUNSATURATED;
FLUOROBENZENES;
HEPTANOIC ACIDS;
HUMANS;
INDOLES;
PRAVASTATIN;
PYRIMIDINES;
PYRROLES;
SIMVASTATIN;
SULFONAMIDES;
|
EID: 45549104507
PISSN: 15748871
EISSN: None
Source Type: Journal
DOI: 10.2174/157488706776876508 Document Type: Review |
Times cited : (13)
|
References (82)
|